07:00 , Sep 13, 2004 |  BC Week In Review  |  Company News

Arc Pharma other research news

Researchers published in Inflammation Research that in a rat model of surgical adhesion disease, camptothecin-loaded HA films significantly reduced the mean strength and area of adhesions compared to HA films that were not loaded with...
08:00 , Nov 24, 2003 |  BC Week In Review  |  Company News

Arc Pharma, University of British Columbia deal

ARC received an exclusive worldwide license to the university's IP covering a set of compounds to treat surgical adhesions. Under a 2002 deal, ARC received exclusive worldwide rights to another set of university compounds to...
07:00 , May 19, 2003 |  BC Week In Review  |  Company News

Arc Pharma board of directors update

Arc Pharmaceuticals Inc. , Vancouver, B.C.   Business: Drug delivery, Cancer, Infectious diseases   Appointed: John North, former SVP of scientific affairs and CSO at QLT Inc.  ...
08:00 , Nov 4, 2002 |  BC Week In Review  |  Company News

Arc Pharma, University of British Columbia deal

Arc received exclusive worldwide rights to the university’s IP covering a class of compounds to treat surgical adhesions, arthritis and psoriasis. The university will receive milestones, royalties and an equity stake in Arc. Arc Pharmaceuticals...
07:00 , Sep 23, 2002 |  BC Week In Review  |  Company News

Arc Pharma board of directors update

Arc Pharmaceuticals Inc. , Vancouver, B.C.   Business: Drug delivery, Cancer, Infectious diseases   Appointed: William Adams, CFO and VP of finance at AnorMed Inc. ; and Jerry Gray, dean of the I.H. Asper School...
07:00 , Sep 23, 2002 |  BC Week In Review  |  Company News

Arc Pharma management update

Arc Pharmaceuticals Inc. , Vancouver, B.C.   Business: Drug delivery, Cancer, Infectious diseases   Departed: Jeff Peitsch as interim CEO, while remaining a director   Hired: Bruce Hay as CFO and a director, formerly CFO...
07:00 , Aug 19, 2002 |  BC Week In Review  |  Company News

Arc Pharma, McGill University deal

The parties will develop antisense therapeutics to treat cancer. The deal combines Arc's polymeric drug delivery technology with the university's antisense technology. Arc has an option to exclusively license resulting compounds. Separately, Arc received an...
07:00 , Jul 1, 2002 |  BC Week In Review  |  Company News

Arc Pharma scientific advisory board update

Arc Pharmaceuticals Inc. , Vancouver, B.C.   Business: Drug delivery, Cancer, Infectious diseases   Appointed: Michael Diamond, professor of obstetrics and gynecology at Wayne State University School of Medicine; and Victor Gomel, former professor of...